Opportunity Information: Apply for PA 07 349
Apply for PA 07 349
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "AIDS Science Track Award for Research Transition (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Apr 3, 2007.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public and State controlled institutions of higher education City or township governments For profit organizations other than small businesses Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Private institutions of higher education County governments.
- Foreign institutions are eligible to apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The AIDS Science Track Award for Research Transition (A START) (R03) is a National Institutes of Health (NIH) grant opportunity, led by the National Institute on Drug Abuse (NIDA), aimed at bringing new and early career investigators into HIV/AIDS-focused drug abuse research. NIDA identifies HIV/AIDS as a major priority area, and this announcement is structured as a practical entry point for researchers who are transitioning into this field or building an initial track record. The central idea is to help investigators generate early data, test concepts, and develop focused projects that can later grow into larger, more comprehensive research programs.
This funding opportunity uses the Small Research Grant (R03) mechanism, which is typically designed for smaller, clearly defined studies rather than large multi-year research programs. Under this FOA, applicants are encouraged to propose work such as feasibility or pilot studies, secondary analysis of existing datasets, or small, self-contained projects that can be completed with modest resources. The research scope is specifically centered on the intersection of drug abuse and HIV/AIDS, meaning the proposed work should directly address questions where substance use, addiction, or drug-related behaviors influence HIV risk, transmission, prevention, treatment outcomes, or related public health concerns.
The opportunity is listed as a discretionary grant program under the NIH, within the broader activity category of education and health. It is associated with CFDA number 93.279 (Drug Abuse and Addiction Research Programs). There is no cost sharing or matching requirement, which reduces barriers for applicants who may not have institutional or external funds to contribute to the project budget.
Eligibility is broad and includes many organization types. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), small businesses and other for-profit organizations (with small businesses explicitly listed, and other for-profits also allowed), state and local governmental entities (such as state governments, county governments, city or township governments, independent school districts, and special district governments), and public housing authorities/Indian housing authorities. Native American tribal governments (federally recognized) and other tribal organizations are also eligible. Importantly, foreign institutions may apply, and faith-based and community-based organizations are eligible as well, which reflects an emphasis on reaching a diverse research community and potentially supporting projects grounded in real-world service settings.
Key timing details reflect that the program accepted applications on multiple receipt dates rather than a single deadline, with applicants directed to the full announcement for the specific schedule. The opportunity was originally posted on April 3, 2007, and later archived on October 8, 2009. Even though it is archived, the listing is still useful as a reference for understanding the intent, structure, and expectations of the A START R03 mechanism and for tracking how similar NIDA/NIH opportunities are framed.
For applicants looking for the official announcement and full requirements, the FOA is identified by Funding Opportunity Number PA-07-349, titled "AIDS Science Track Award for Research Transition (R03)." The full text was available through the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PA-07-349.html. Assistance with accessing the announcement or resolving link issues is routed through the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.
FAQs: AIDS Science Track Award for Research Transition (A START) (R03)
What is the A START (R03) grant opportunity?
The AIDS Science Track Award for Research Transition (A START) (R03) is a National Institutes of Health (NIH) funding opportunity led by the National Institute on Drug Abuse (NIDA). It is intended as an entry point for investigators who are new to, or transitioning into, HIV/AIDS-focused drug abuse research.
What is the main purpose of this funding opportunity?
The purpose is to help new and early career investigators generate early data, test concepts, and develop focused, self-contained projects that can serve as a foundation for larger and more comprehensive research programs later on.
Which NIH institute leads this opportunity?
This opportunity is led by the National Institute on Drug Abuse (NIDA) within the NIH.
What research area does this opportunity prioritize?
The program targets research at the intersection of drug abuse and HIV/AIDS. Proposed work should address questions where substance use, addiction, or drug-related behaviors affect HIV risk, transmission, prevention, treatment outcomes, or related public health concerns.
What grant mechanism does A START use?
This funding opportunity uses the NIH Small Research Grant (R03) mechanism, which is generally meant for smaller, clearly defined projects rather than large multi-year research programs.
What kinds of projects are encouraged under this R03?
Applicants are encouraged to propose modest, focused work such as feasibility studies, pilot studies, secondary analyses of existing datasets, or other small, self-contained projects that can be completed with limited resources.
Is this opportunity meant for large-scale research programs?
No. Based on the R03 mechanism described, it is designed for smaller studies and early-stage research steps, not large, multi-year research programs.
What is the CFDA number associated with this program?
The opportunity is associated with CFDA number 93.279, listed as Drug Abuse and Addiction Research Programs.
Does the program require cost sharing or matching funds?
No. The listing specifies there is no cost sharing or matching requirement.
What types of organizations are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (with small businesses explicitly listed and other for-profits also allowed), and a range of government entities.
Are state and local government entities eligible?
Yes. Eligible entities include state governments, county governments, city or township governments, independent school districts, and special district governments.
Are tribal governments and tribal organizations eligible?
Yes. Native American tribal governments (federally recognized) and other tribal organizations are listed as eligible.
Can foreign institutions apply?
Yes. The information provided indicates that foreign institutions may apply.
Are faith-based or community-based organizations eligible?
Yes. Faith-based and community-based organizations are stated to be eligible.
Are public housing authorities eligible applicants?
Yes. Public housing authorities and Indian housing authorities are included among eligible applicants.
Is this opportunity described as mandatory or discretionary?
It is listed as a discretionary grant program under the NIH.
When was this funding opportunity posted and when was it archived?
The opportunity was originally posted on April 3, 2007, and it was archived on October 8, 2009.
Can applications still be submitted if the opportunity is archived?
The information provided states the listing is archived and is useful as a reference for understanding the intent, structure, and expectations of the A START R03 mechanism. It does not indicate that applications can still be submitted.
How were application deadlines handled?
The program accepted applications on multiple receipt dates rather than a single deadline, and applicants were directed to the full announcement for the specific schedule.
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PA-07-349.
What is the official title of the FOA?
The FOA title is "AIDS Science Track Award for Research Transition (R03)."
Where could applicants find the full announcement text?
The full text was available through the NIH Grants Guide at: http://grants.nih.gov/grants/guide/pa-files/PA-07-349.html
Who is the contact for help with the announcement link or access issues?
Assistance with accessing the announcement or resolving link issues is routed through the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.
What is NIDA's stated priority connection to this opportunity?
NIDA identifies HIV/AIDS as a major priority area, and this announcement is structured to bring new and early career investigators into HIV/AIDS-focused drug abuse research.
What is the practical benefit of this FOA for transitioning investigators?
It is framed as a practical entry point to help investigators build an initial track record in the field by producing early results, preliminary data, or proof-of-concept findings that can support future, larger projects.
What general activity category is this opportunity associated with?
It is described as being within a broader activity category of education and health.
Browse more opportunities from the same category: Education Health
Next opportunity: Bioengineering Research Partnerships (BRP)R01
Previous opportunity: Developing And Improving Institutional Animal Resources (G20)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 349
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 349) also looked into and applied for these:
| Funding Opportunity |
|---|
| Bioengineering and Obesity (R01) Apply for PA 07 354 Funding Number: PA 07 354 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Improving Heart Failure Disease Management (R01) Apply for PA 07 355 Funding Number: PA 07 355 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical Cancer Therapy and Prevention Research (R01) Apply for PA 07 356 Funding Number: PA 07 356 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21) Apply for PA 07 362 Funding Number: PA 07 362 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Cannabis Related Disorders (R01) Apply for PA 07 365 Funding Number: PA 07 365 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Cannabis Related Disorders (R21) Apply for PA 07 366 Funding Number: PA 07 366 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Omics and Variable Responses to CAM Secondary Analysis of CAM Clinical Trials (R01) Apply for PAR 07 377 Funding Number: PAR 07 377 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Omics and Variable Responses to CAM Secondary Analysis of CAM Clinical Trials (R21) Apply for PAR 07 378 Funding Number: PAR 07 378 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Nutrition and Alcohol Related Health Outcomes (R01) Apply for PA 07 403 Funding Number: PA 07 403 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Nutrition and Alcohol Related Health Outcomes (R03) Apply for PA 07 404 Funding Number: PA 07 404 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Genetic Epidemiology of Substance Use Disorders(R01) Apply for PA 07 413 Funding Number: PA 07 413 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Genetic Epidemiology of Substance Use Disorders (R03) Apply for PA 07 414 Funding Number: PA 07 414 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Genetic Epidemiology of Substance Use Disorders(R21) Apply for PA 07 415 Funding Number: PA 07 415 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R21) Apply for PA 07 421 Funding Number: PA 07 421 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R01) Apply for PA 07 422 Funding Number: PA 07 422 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 07 454 Funding Number: PA 07 454 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 07 455 Funding Number: PA 07 455 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Continued Development and Maintenance of Software (R01) Apply for PAR 08 010 Funding Number: PAR 08 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Angiogenesis in the Nervous System in Health and Disease (R01) Apply for PA 08 015 Funding Number: PA 08 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Angiogenesis in the Nervous System in Health and Disease (R21) Apply for PA 08 016 Funding Number: PA 08 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 349", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.